Cigna’s $0.9B Volume Slides to 130th Rank as Stock Falls 1.93% on Cost and Regulatory Concerns

Cigna (CI) closed August 1, 2025, with a trading volume of $0.90 billion, a 40.24% decline from the prior day, ranking 130th in the market. The stock fell 1.93% despite robust Q2 2025 earnings, reflecting ongoing concerns over cost pressures and regulatory risks.

The company reported Q2 revenue of $67.2 billion and adjusted EPS of $7.20, reaffirming its full-year 2025 guidance of at least $29.60 per share. Evernorth, Cigna’s pharmacy and specialty care segment, drove growth with $57.8 billion in revenue, including a 13% increase in Specialty and Care Services. However, elevated medical costs in specialty injectables and behavioral health services strained margins, with the Medical Care Ratio (MCR) rising to 83.2%. Cigna Healthcare, which includes U.S. and international health plans, saw an 18% revenue decline due to the divestiture of Medicare businesses.

Leadership emphasized strategic initiatives to mitigate margin pressures, including AI-driven cost management and GLP-1 affordability programs. Evernorth’s Pharmacy Benefit Services reported $833 million in adjusted pre-tax earnings, while Cigna Healthcare’s pre-tax profit rose to $1.1 billion. The company also highlighted progress in reducing its SG&A expense ratio to 4.9%, down from 6.0% year-over-year.

Despite these efforts, challenges persist. Cigna’s individual exchange business has scaled back its customer base, reducing it by 60% since 2023, and stop-loss margins remain under pressure. Regulatory developments, including Arkansas’ PBM legislation, and rising healthcare inflation could further impact profitability. Analysts noted that while Cigna’s innovation and operational efficiency are strengths, its ability to balance growth with margin stability will determine long-term success.

The strategy of purchasing the top 500 stocks by daily trading volume and holding them for one day delivered a 166.71% return from 2022 to the present, outperforming the benchmark return of 29.18% by 137.53%. This underscores the role of liquidity concentration in short-term stock performance, particularly in volatile markets.